SK bioscience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	305,744	312,702	127,026	225,287	98,028
Short-Term Investments	233,546	233,542	275,300	5,300	-0
Trading Asset Securities	644,272	611,864	871,816	1,250,218	1,547,635
Cash & Short-Term Investments	1,183,562	1,158,108	1,274,141	1,480,806	1,645,663
Cash Growth	-5.56%	-9.11%	-13.96%	-10.02%	-
Accounts Receivable	111,326	94,462	12,928	39,585	38,006
Other Receivables	19,806	93,934	9,414	50,076	10,129
Receivables	131,132	188,396	22,342	89,661	48,135
Inventory	216,782	211,126	80,649	187,406	135,046
Prepaid Expenses	17,142	5,748	1,613	1,649	1,407
Other Current Assets	1,770	13,295	4,224	24,173	7,554
Total Current Assets	1,550,388	1,576,673	1,382,969	1,783,694	1,837,804
Property, Plant & Equipment	1,040,840	982,607	315,923	293,057	220,983
Long-Term Investments	20,001	22,357	42,729	1,500	21,610
Goodwill	59,657	57,436	-	-	-
Other Intangible Assets	58,814	56,084	14,178	6,299	3,973
Long-Term Deferred Tax Assets	130,625	108,135	59,219	21,370	10,242
Long-Term Deferred Charges	16,885	11,027	8,281	11,882	13,088
Other Long-Term Assets	24,893	29,277	29,140	24,129	2,422
Total Assets	2,902,103	2,843,596	1,852,439	2,141,931	2,110,123
Accounts Payable	31,159	17,818	3,370	11,053	63,812
Accrued Expenses	54,977	54,298	19,716	30,242	26,322
Short-Term Debt	-	-	-	45,550	11,671
Current Portion of Long-Term Debt	-	-	-	38,008	47,978
Current Portion of Leases	6,636	6,957	8,137	12,235	2,309
Current Income Taxes Payable	4,793	6,994	-	20,216	101,486
Other Current Liabilities	250,001	224,523	104,397	222,733	206,374
Total Current Liabilities	347,565	310,589	135,620	380,037	459,952
Long-Term Debt	395,110	383,331	-	-	35,503
Long-Term Leases	1,434	2,526	12,436	17,543	8,775
Long-Term Deferred Tax Liabilities	73,729	71,960	-	-	-
Other Long-Term Liabilities	43,873	52,737	527.84	2,649	335.24
Total Liabilities	861,712	821,144	148,584	400,229	508,811
Common Stock	39,174	39,174	38,414	38,392	38,250
Additional Paid-In Capital	1,235,376	1,235,376	1,160,456	1,160,008	1,157,064
Retained Earnings	492,292	499,757	549,421	533,378	405,305
Comprehensive Income & Other	41,541	28,258	-44,435	9,924	692.92
Total Common Equity	1,808,383	1,802,565	1,703,855	1,741,702	1,601,312
Minority Interest	232,008	219,887	-	-	-
Shareholders' Equity	2,040,391	2,022,452	1,703,855	1,741,702	1,601,312
Total Liabilities & Equity	2,902,103	2,843,596	1,852,439	2,141,931	2,110,123
Total Debt	403,180	392,814	20,574	113,336	106,236
Net Cash (Debt)	780,382	765,294	1,253,568	1,367,469	1,539,428
Net Cash Growth	-32.29%	-38.95%	-8.33%	-11.17%	-
Net Cash Per Share	10058.89	9912.96	16277.20	17754.39	20850.38
Filing Date Shares Outstanding	78.35	78.35	76.83	76.78	76.5
Total Common Shares Outstanding	78.35	78.35	76.83	76.78	76.5
Working Capital	1,202,822	1,266,083	1,247,350	1,403,657	1,377,852
Book Value Per Share	23081.62	23007.37	22177.60	22683.12	20932.18
Tangible Book Value	1,689,911	1,689,045	1,689,678	1,735,403	1,597,339
Tangible Book Value Per Share	21569.49	21558.43	21993.06	22601.09	20880.24
Land	72,314	71,307	45,280	45,270	9,949
Buildings	432,308	425,887	124,315	127,741	119,990
Machinery	175,411	174,922	55,879	53,141	51,037
Construction In Progress	283,362	231,274	65,638	33,153	25,884

Source: S&P Global Market Intelligence. Standard template. Financial Sources.